Form 4: Director Gladden Boosts DENTSPLY SIRONA Stake

DENTSPLY SIRONA Director Brian T. Gladden acquired 286.094 shares of common stock through RSU dividends.

Summary

• Brian T. Gladden, a Director of DENTSPLY SIRONA Inc. (XRAY), acquired 286.094 shares of common stock.
• The transaction occurred on October 10, 2025, and was an acquisition (Code A).
• These shares were acquired at a price of $0 per share.
• The acquisition represents dividends on previously awarded restricted stock units (RSUs), issued in the form of additional RSUs.
• These dividend RSUs are subject to the same vesting terms as the underlying awards and vest simultaneously.
• Each RSU converts to common stock on a 1:1 basis.
• Following this transaction, Brian T. Gladden beneficially owns a total of 28,726.563 shares of DENTSPLY SIRONA common stock.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction related to RSU dividends, which is a neutral event in terms of company performance or strategic direction. It reflects standard compensation practices.

Positives

• A director's beneficial ownership in the company increased, which can signal alignment of interests with shareholders.
• The acquisition of shares through RSU dividends is a routine part of executive compensation, reflecting ongoing participation in the company's equity program.

Future Outlook

The acquired restricted stock units (RSUs) are subject to the same vesting terms as their underlying awards, indicating future conversion to common stock upon meeting these conditions.

Industry Context

This filing is a routine insider transaction related to executive compensation and does not provide specific insights into broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: The transaction slightly increases a director's beneficial ownership, potentially aligning management interests with shareholder value over the long term.
• Employees (specifically Brian T. Gladden): Represents a routine component of his equity compensation, increasing his stake in the company.

Next Steps

• The acquired restricted stock units (RSUs) will vest according to their predetermined schedules, at which point they will convert into common stock.

Key Dates

Keywords

DENTSPLY SIRONA, XRAY, Brian T. Gladden, Form 4, insider transaction, RSU, restricted stock units, director, beneficial ownership, equity compensation